Cambridge Capital Group

Cambridge GaN Devices specializes in the development and commercialization of gallium nitride (GaN) power devices aimed at improving energy efficiency in electronic applications. The company offers a variety of GaN-based semiconductor products that enhance power conversion and minimize energy loss across different systems. These advanced devices find applications in sectors such as renewable energy, electric vehicles, and consumer electronics, supporting the shift towards more sustainable technologies. Cambridge GaN Devices focuses on creating transistors that are faster, more compact, and more efficient than traditional silicon alternatives, thereby enabling industries to utilize tailored semiconductors for critical applications. The company collaborates with industry partners to promote innovation and facilitate the integration of its technology into the power semiconductor market.

Spotta Ltd is a company that specializes in developing smart pest control systems aimed at the hotel and lodging industry, focusing on the early detection of bed bugs. Founded in 2018 and headquartered in Cambridge, United Kingdom, Spotta offers a battery-powered insect monitoring sensor that alerts users to potential bed bug infestations. This innovative technology analyzes detection data to ensure that notifications pertain only to genuine incidents, allowing hotels to proactively prevent bed bugs from spreading and facilitating more efficient and cost-effective treatment options. By leveraging these systems, lodging providers can enhance guest satisfaction and maintain a pest-free environment.

Cytochroma manufacture genetically diverse stem cell-derived models to predict the safety and effect of drugs in a global population. Cytochroma’s automated cell manufacture, physiologically relevant models and rapid screening platform makes preclinical testing faster, safer and smarter.

Qualus is a provider of sustainable solutions for the leather industry, focused on reducing the environmental impact of leather tanneries. The company has developed a technology that employs Sferes, which are small polymer granules designed to help tanneries save water, lower production costs, and enhance the quality of leather. By integrating this technology, Qualus enables its customers to decrease their energy consumption and carbon footprint while also lowering operational expenses. Recently, the company secured £3 million in financing from Irrus Investments, along with co-investments from CPI Enterprises and angel investors from Cambridge Capital Group and Harvard Business School Alumni Angels of London.

Cambridge GaN Devices specializes in the development and commercialization of gallium nitride (GaN) power devices aimed at improving energy efficiency in electronic applications. The company offers a variety of GaN-based semiconductor products that enhance power conversion and minimize energy loss across different systems. These advanced devices find applications in sectors such as renewable energy, electric vehicles, and consumer electronics, supporting the shift towards more sustainable technologies. Cambridge GaN Devices focuses on creating transistors that are faster, more compact, and more efficient than traditional silicon alternatives, thereby enabling industries to utilize tailored semiconductors for critical applications. The company collaborates with industry partners to promote innovation and facilitate the integration of its technology into the power semiconductor market.

Porotech is a spin-out from the University of Cambridge that specializes in the development of gallium nitride (GaN) semiconductor technologies. Co-founded by Dr. Tongtong Zhu, Dr. Yingjun Liu, and Prof. Rachel Oliver, the company focuses on creating energy-efficient wide-bandgap semiconductors through advanced material technologies. By harnessing the potential of GaN, Porotech aims to enhance the efficiency of light-emitting diodes and various electronic devices, thereby contributing to innovations in the electronics industry.

SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.

SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, particularly through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging tool allows for real-time detection of cancer during surgical procedures, which can significantly reduce the chances of cancer recurrence and the necessity for reoperations. By optimizing the performance of robotic cancer surgery, Lightpoint Medical aims to provide healthcare professionals with advanced tools that enhance surgical decision-making and improve patient outcomes, ultimately contributing to cost savings within the healthcare system.

Sorex Sensors Limited specializes in the design and manufacture of film bulk acoustic resonator (FBAR) technology-based micro-electro-mechanical system (MEMS) mass sensors for various industrial and consumer applications. Founded in 2017 and headquartered in the United Kingdom, the company fabricates its devices on silicon wafers, utilizing a thin film of piezoelectric material that resonates to detect mass changes accurately. These sensors are capable of measuring mass down to the femtogram range and can simultaneously monitor temperature with a resolution of 0.2 °C. Their small size and low power consumption make them suitable for diverse applications, including thin film metrology, particulate monitoring, and gas detection. Additionally, the surface of the sensors can be functionalized to selectively detect specific targets, enhancing their versatility in detecting harmful compounds in various environments, such as homes and workplaces.

Danio Lab is dedicated to advancing biomedical research by offering innovative services and tools to the scientific community. The company specializes in a zebrafish husbandry platform and provides comprehensive solutions, including aquatics room layout and system design. These services support researchers in upgrading existing aquatics facilities or constructing new laboratories tailored to their needs. By focusing on these specialized offerings, Danio Lab aims to enhance the efficiency and effectiveness of research involving zebrafish models.

SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

DefiniGEN Limited specializes in providing human cell products for the life science and drug discovery sectors, focusing on applications in predictive toxicology, metabolic diseases, and regenerative medicine. The company’s product offerings include wild-type human hepatocytes and pancreatic cells for research in diabetes, alongside disease-modelled cells for conditions such as glycogen storage disease and hypercholesterolemia. DefiniGEN leverages its advanced stem cell production platform, developed at the University of Cambridge, to create high-functionality cell types that enhance drug discovery processes. The company also offers a range of services, including custom cell production, gene-editing, and diabetes compound profiling, catering primarily to pharmaceutical companies. Established in 2011 and based in Cambridge, UK, DefiniGEN builds on its strong intellectual property foundation, including expertise in induced pluripotent stem cell technology.

Spectral Edge is a technology company focused on developing advanced image processing and enhancement solutions. It utilizes patented image fusion technology combined with deep learning to improve the quality and visibility of images, particularly for individuals with color vision deficiencies. By leveraging the full spectrum of color, Spectral Edge's technology enables the display of multi-modal images that enhance detail and clarity without introducing artifacts. This innovation aims to benefit application developers and enhance the user experience across mass-market devices, allowing for richer and more accessible visual content.

SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.

Arquer Diagnostics Ltd. specializes in the design, development, and commercialization of non-invasive diagnostic tests for bladder and prostate cancer. The company offers an enzyme-linked immunosorbent assay (ELISA) for measuring specific substances in bodily fluids, including a CE-marked ELISA kit for Mcm5, which is utilized in hospital laboratories. Additionally, Arquer provides a point-of-care system that features a robust reader instrument and disposable cartridges, making it suitable for urology clinics, hospital laboratories, and general practitioners' surgeries. Founded in 2005 and based in Sunderland, United Kingdom, the company was previously known as UroSens Ltd. before rebranding in July 2015. Arquer’s patented technology allows for accurate and reliable detection of the MCM5 protein, aiding in cancer diagnosis and monitoring.

Lightpoint Medical, Ltd. is a medical device company based in Rickmansworth, United Kingdom, founded in 2012. The company specializes in developing innovative imaging technologies for cancer surgery, particularly through its Cerenkov Luminescence Imaging (CLI) technology. This breakthrough intraoperative imaging tool allows for real-time detection of cancer during surgical procedures, which can significantly reduce the chances of cancer recurrence and the necessity for reoperations. By optimizing the performance of robotic cancer surgery, Lightpoint Medical aims to provide healthcare professionals with advanced tools that enhance surgical decision-making and improve patient outcomes, ultimately contributing to cost savings within the healthcare system.

SupaPass is a comprehensive platform that enables businesses to create their own websites and mobile applications without needing technical expertise. Founded in 2011, SupaPass offers an innovative white-label solution that allows clients to launch payment-ready content-driven websites and apps quickly and affordably. The platform is designed to meet the needs of various sectors including podcasting, fitness, music, and charities, providing users with tools to manage content such as podcasts, videos, and streaming channels in a manner similar to popular services like Netflix. By utilizing SupaPass, clients maintain full ownership of customer data and retain 100% of their sales, all while benefiting from a more cost-effective and efficient alternative to custom-built solutions. The platform empowers content owners to engage directly with their audiences, facilitating a regular revenue stream and enhancing their brand presence online.

10to8 Limited is a company that specializes in developing appointment scheduling software solutions designed for a wide range of sectors, including healthcare, beauty, sports, and professional services. Founded in September 2011 by Matthew Cleevely, Bruce Johnson, Tom Playford, and Nigel Playford, the company is headquartered in Cambridge, United Kingdom. Its online booking system allows users to reserve available time slots for various events and efficiently manage team availability. By serving diverse industries such as trades, tutoring, and therapy, 10to8 aims to streamline appointment management and enhance customer engagement for businesses around the world.

PneumaCare Limited specializes in the development of non-invasive systems for assessing and monitoring lung function, particularly for vulnerable populations such as infants, intensive care patients, and the elderly. Founded in 2008 and based in Ely, United Kingdom, the company utilizes innovative 3D imaging technology originally developed at the University of Cambridge. Its flagship product, PneumaScan, employs structured light plethysmography to capture motion and analyze chest and abdominal wall movement during breathing. This system allows for respiratory assessments without requiring direct contact, enabling patients to breathe naturally or perform specific maneuvers without the discomfort associated with traditional spirometers. PneumaCare's range of products, including Thora-3Di and PneumaView 3D, aims to provide clinicians with comprehensive insights into various patient types while minimizing infection risks and improving comfort. The technology is currently under evaluation in several clinical settings, including prominent hospitals in Cambridge and London.

Anvil Semiconductors Ltd specializes in the development of silicon carbide (SiC) materials and devices aimed at the power electronics and LED markets. Founded in 2010 as a spin-out from the University of Warwick, the company holds multiple patents in SiC power semiconductor technology. Anvil produces vertical Schottky barrier diodes (SBDs) and MOSFETs using 3C-SiC on silicon wafers, which are supplied and licensed to various sectors within the power electronics market. The company’s innovative materials not only facilitate the fabrication of SiC devices but also support the growth of other compound semiconductor structures on silicon. Anvil's products have diverse applications, including photovoltaics, electric vehicle charging, consumer electronics power conversions, uninterruptible power supplies, and LED lighting. With headquarters in Coventry and an additional office in Cambridge, Anvil aims to deliver SiC-based devices that match the costs of traditional silicon devices while providing enhanced operational efficiency.

Eagle Genomics is an enterprise software solutions company focused on managing and analyzing genomics and life sciences data. Its suite of products helps life science companies maximize the value of their research and development data by transforming data sets into actionable assets, thereby improving productivity and reducing costs and time in research processes. The company's platform offers an intuitive approach for curating, integrating, sharing, and analyzing scientific data, addressing the challenges faced by industries such as pharmaceuticals, consumer goods, and agri-tech. With a unique combination of expertise in biology, bioinformatics, data science, and software engineering, Eagle Genomics is well-positioned to tackle the complexities of data management in the genomics era, providing clarity on the value of digital assets and the return on information.

SwiftKey is a technology company based in London, United Kingdom, founded in 2008 by Ben Medlock and Jon Reynolds. The company specializes in developing a smart and customizable keyboard that enhances typing efficiency on mobile devices. By leveraging artificial intelligence, SwiftKey's software learns from individual user behavior to provide accurate auto-correction and word predictions tailored to their writing style. The SwiftKey Keyboard supports over 80 languages, making it accessible to a diverse user base. The company's innovations aim to improve the interaction between users and their keyboards, ultimately facilitating faster and more intuitive typing experiences.

Cambridge Communication Systems Limited, based in Cambridge, United Kingdom, specializes in designing and developing self-organizing wireless backhaul solutions. Founded in 2010, the company focuses on providing cost-effective connectivity for various applications, including small cells, Wi-Fi, CCTV, and smart city infrastructure. Its flagship product, Metnet, features self-organizing 5G microwave backhauls and is complemented by the Metnet SON Multipoint solution, which operates in the 24/26/28GHz frequency range. The company's technology enables intelligent, self-optimizing, and self-healing mesh networks, allowing network operators to extend fiber connectivity effectively. This approach facilitates the development of hybrid fiber-wireless networks that cater to diverse environments, from urban to rural areas, and supports a wide range of users from residential to enterprise settings.

Featurespace is a leader in enterprise financial crime prevention, specializing in fraud detection and anti-money laundering solutions. The company has developed innovative technologies, including Adaptive Behavioral Analytics and Automated Deep Behavioral Networks, which are incorporated into its ARIC platform. This real-time machine learning software assesses risk and monitors customer data across more than 180 countries to identify fraudulent activities and suspicious behavior promptly. The ARIC Risk Hub utilizes advanced anomaly detection methods, allowing financial institutions to automatically recognize potential threats and respond to them effectively. Over 30 major global financial institutions, including well-known names such as HSBC and NatWest, leverage Featurespace’s solutions to safeguard their operations and enhance customer satisfaction while minimizing fraud-related costs.

Cambridge Communication Systems Limited, based in Cambridge, United Kingdom, specializes in designing and developing self-organizing wireless backhaul solutions. Founded in 2010, the company focuses on providing cost-effective connectivity for various applications, including small cells, Wi-Fi, CCTV, and smart city infrastructure. Its flagship product, Metnet, features self-organizing 5G microwave backhauls and is complemented by the Metnet SON Multipoint solution, which operates in the 24/26/28GHz frequency range. The company's technology enables intelligent, self-optimizing, and self-healing mesh networks, allowing network operators to extend fiber connectivity effectively. This approach facilitates the development of hybrid fiber-wireless networks that cater to diverse environments, from urban to rural areas, and supports a wide range of users from residential to enterprise settings.

SwiftKey is a technology company based in London, United Kingdom, founded in 2008 by Ben Medlock and Jon Reynolds. The company specializes in developing a smart and customizable keyboard that enhances typing efficiency on mobile devices. By leveraging artificial intelligence, SwiftKey's software learns from individual user behavior to provide accurate auto-correction and word predictions tailored to their writing style. The SwiftKey Keyboard supports over 80 languages, making it accessible to a diverse user base. The company's innovations aim to improve the interaction between users and their keyboards, ultimately facilitating faster and more intuitive typing experiences.

Arachnys Information Services Limited, founded in 2010 and based in Cambridge, United Kingdom, specializes in developing cloud-based solutions that enhance the assessment of financial crime risks and compliance with customer due diligence, know your customer, and enhanced due diligence regulations. The company offers a web crawler and deep-web search engine that enables access to hard-to-reach information, particularly from emerging markets such as India, China, Russia, and the Middle East. Arachnys addresses the challenges posed by fragmented and disorganized data in these regions by employing advanced spidering and scraping technology, which allows businesses to extract valuable insights from siloed corporate and governmental datasets. Its services cater to investment banks, hedge funds, law firms, accountants, and risk consultancies seeking growth opportunities in complex markets while minimizing associated risks.

PneumaCare Limited specializes in the development of non-invasive systems for assessing and monitoring lung function, particularly for vulnerable populations such as infants, intensive care patients, and the elderly. Founded in 2008 and based in Ely, United Kingdom, the company utilizes innovative 3D imaging technology originally developed at the University of Cambridge. Its flagship product, PneumaScan, employs structured light plethysmography to capture motion and analyze chest and abdominal wall movement during breathing. This system allows for respiratory assessments without requiring direct contact, enabling patients to breathe naturally or perform specific maneuvers without the discomfort associated with traditional spirometers. PneumaCare's range of products, including Thora-3Di and PneumaView 3D, aims to provide clinicians with comprehensive insights into various patient types while minimizing infection risks and improving comfort. The technology is currently under evaluation in several clinical settings, including prominent hospitals in Cambridge and London.

Oval Medical Technologies Limited, based in Cambridge, United Kingdom, specializes in the design and development of drug delivery devices, including vials, prefilled syringes, and autoinjectors. Founded in 2009, the company focuses on creating next-generation autoinjectors that enable patients of various ages and from different therapeutic areas to self-administer medications safely and effectively. Oval Medical's technology utilizes cyclic olefin plastic, allowing for the delivery of both viscous and non-viscous drugs. The company primarily serves the pharmaceutical and biotechnology industries, providing innovative solutions to enhance drug delivery and patient compliance. As of December 2016, it operates as a subsidiary of SMC Ltd.

Augmentra Ltd is a company based in Cambridge, United Kingdom, that specializes in outdoor navigation through its flagship product, ViewRanger. Launched in 2006, ViewRanger is a GPS navigation software application that assists users in planning, navigating, recording, and sharing their outdoor adventures, making it an essential tool for activities such as walking, hiking, and biking. As of May 2020, Augmentra operates as a subsidiary of Outdooractive GmbH, expanding its reach and capabilities in the outdoor activity sector. The application incorporates features such as augmented reality to enhance user experience, serving millions of active individuals seeking to explore the outdoors.

Enval Limited specializes in the design and manufacture of recycling equipment and modular plants that utilize microwave-induced pyrolysis for recycling plastic-aluminium laminates. Founded in 2005 as a spin-out from the Department of Chemical Engineering at the University of Cambridge, the company addresses environmental and regulatory challenges across various sectors, including industrial, commercial, and municipal markets. Enval provides expert solutions that transform waste into valuable resources, catering to waste handlers, local authorities, fast-moving consumer goods brands, and individual consumers. In addition to its proprietary recycling technology, the company offers environmental life cycle analysis and technology consultancy, focusing on the pyrolytic recycling of complex flexible packaging materials. Enval's innovative approach aims to create sustainable alternatives to landfills by extracting commercially usable aluminum, oil, and gas from materials such as drink cartons and toothpaste tubes. Based in Huntingdon, United Kingdom, Enval is committed to advancing recyclability and promoting a circular economy.

Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, focused on developing innovative antibiotics to combat antibacterial resistance. Utilizing its SASPject platform, the company delivers anti-bacterial proteins, including small acid-soluble spore proteins, to specific bacterial species through targeted non-delivery vehicles. Phico's product pipeline includes SASPject PT3, an antibiotic aimed at Pseudomonas aeruginosa; SASPject PT4 and PT5, designed for systemic use against Klebsiella pneumonia and Escherichia coli; and SASPject PT1.2, which targets Staphylococcus aureus. Additionally, the company is developing an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses along with antibacterial proteins to inhibit bacterial reproduction and toxin release. Founded in 2000, Phico Therapeutics is committed to advancing solutions for pressing healthcare challenges posed by antibiotic resistance.

Nujira specializes in power amplifier technology for the wireless communications industry, focusing on high-efficiency solutions for 3G and fourth-generation cellular terminals, as well as digital broadcast transmitters. The company is known for its High Accuracy Tracking (HAT) Power Modulators, which help equipment manufacturers create smaller, more affordable, and energy-efficient base stations and transmitters. With a strong emphasis on envelope tracking technology, Nujira addresses the growing demands of operators and broadcasters by enhancing the performance and efficiency of broadband RF power amplifiers. The company holds over 200 patents related to envelope tracking, underscoring its commitment to innovation in the sector.

Metalysis Limited is a technology company based in Rotherham, United Kingdom, specializing in the manufacture of high-value metals and alloys, including titanium and tantalum. Founded in 2001, the company employs a solid-state process developed from research at the University of Cambridge to produce metal alloy powders that are primarily utilized in advanced manufacturing sectors such as aerospace and automotive. This innovative method is designed to be more environmentally friendly and energy-efficient compared to traditional melting technologies. Metalysis also provides powder metallurgy, additives, and analytical services, and has established commercial partnerships with various industry and academic entities. The company's Generation 4 technological expansion aims to scale production to industrial levels, further enhancing its capabilities in delivering 3D printable metal powders for diverse applications.

Nujira specializes in power amplifier technology for the wireless communications industry, focusing on high-efficiency solutions for 3G and fourth-generation cellular terminals, as well as digital broadcast transmitters. The company is known for its High Accuracy Tracking (HAT) Power Modulators, which help equipment manufacturers create smaller, more affordable, and energy-efficient base stations and transmitters. With a strong emphasis on envelope tracking technology, Nujira addresses the growing demands of operators and broadcasters by enhancing the performance and efficiency of broadband RF power amplifiers. The company holds over 200 patents related to envelope tracking, underscoring its commitment to innovation in the sector.

Kaptivo is a developer of a whiteboard camera that enhances visual collaboration through artificial intelligence. Its product enables live-streamed whiteboard content during remote meetings, incorporating features such as automatic note-taking to facilitate communication and productivity. Kaptivo's technology is utilized by businesses and educational institutions, allowing them to seamlessly integrate with popular collaboration tools like Zoom, Cisco Webex, Microsoft Teams, and Slack. This integration supports secure content sharing, ultimately improving the efficiency of remote interactions.

Ubisense is a leading provider of Precise Real-Time Location Systems, specializing in enterprise business automation through advanced tracking of people and assets. The company offers a real-time enterprise location platform designed to assist organizations in their factory digitization efforts. By generating and interpreting extensive location data, Ubisense creates visibility into real-world objects and their interactions, enabling clients to make informed decisions with greater flexibility and adaptability. The company's innovative solutions address complex business challenges, allowing for enhanced operational efficiency and control.

Camrivox Ltd, founded in 2005 and headquartered in Cambridge, UK, specializes in providing telephony integration solutions for customer relationship management (CRM). The company has developed Flexor Software, which simplifies the integration of telephony with CRM systems, eliminating the need for significant investments in infrastructure and support staff. By delivering this software directly at the PC level, Camrivox enables businesses to enhance their communication processes, streamline operations, and improve customer satisfaction. Additionally, the company manufactures voice-over internet protocol (VoIP) equipment targeted at home users and small businesses, facilitating the integration of telephony, instant messaging, and presence management within CRM services.

Nujira specializes in power amplifier technology for the wireless communications industry, focusing on high-efficiency solutions for 3G and fourth-generation cellular terminals, as well as digital broadcast transmitters. The company is known for its High Accuracy Tracking (HAT) Power Modulators, which help equipment manufacturers create smaller, more affordable, and energy-efficient base stations and transmitters. With a strong emphasis on envelope tracking technology, Nujira addresses the growing demands of operators and broadcasters by enhancing the performance and efficiency of broadband RF power amplifiers. The company holds over 200 patents related to envelope tracking, underscoring its commitment to innovation in the sector.

Metalysis Limited is a technology company based in Rotherham, United Kingdom, specializing in the manufacture of high-value metals and alloys, including titanium and tantalum. Founded in 2001, the company employs a solid-state process developed from research at the University of Cambridge to produce metal alloy powders that are primarily utilized in advanced manufacturing sectors such as aerospace and automotive. This innovative method is designed to be more environmentally friendly and energy-efficient compared to traditional melting technologies. Metalysis also provides powder metallurgy, additives, and analytical services, and has established commercial partnerships with various industry and academic entities. The company's Generation 4 technological expansion aims to scale production to industrial levels, further enhancing its capabilities in delivering 3D printable metal powders for diverse applications.

Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, focused on developing innovative antibiotics to combat antibacterial resistance. Utilizing its SASPject platform, the company delivers anti-bacterial proteins, including small acid-soluble spore proteins, to specific bacterial species through targeted non-delivery vehicles. Phico's product pipeline includes SASPject PT3, an antibiotic aimed at Pseudomonas aeruginosa; SASPject PT4 and PT5, designed for systemic use against Klebsiella pneumonia and Escherichia coli; and SASPject PT1.2, which targets Staphylococcus aureus. Additionally, the company is developing an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses along with antibacterial proteins to inhibit bacterial reproduction and toxin release. Founded in 2000, Phico Therapeutics is committed to advancing solutions for pressing healthcare challenges posed by antibiotic resistance.

Phico Therapeutics Limited is a biotechnology company based in Bourn, United Kingdom, focused on developing innovative antibiotics to combat antibacterial resistance. Utilizing its SASPject platform, the company delivers anti-bacterial proteins, including small acid-soluble spore proteins, to specific bacterial species through targeted non-delivery vehicles. Phico's product pipeline includes SASPject PT3, an antibiotic aimed at Pseudomonas aeruginosa; SASPject PT4 and PT5, designed for systemic use against Klebsiella pneumonia and Escherichia coli; and SASPject PT1.2, which targets Staphylococcus aureus. Additionally, the company is developing an intravenous-engineered bacteriophage drug intended to treat ventilator-associated pneumonia by using engineered bacterial viruses along with antibacterial proteins to inhibit bacterial reproduction and toxin release. Founded in 2000, Phico Therapeutics is committed to advancing solutions for pressing healthcare challenges posed by antibiotic resistance.